19 June 2013
Keywords: fda, extends, review, wyeth, first-in-class, mtor, inhibitor
Article | 16 April 2007
US drug major Wyeth Pharmaceuticals says that the Food and Drug Administration has extended the review of the New Drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 April 2007
23 April 2007
9 April 2007
© 2013 thepharmaletter.com